MyFinsight
Home
Blog
About
Income Statement
|
Cash Flow
|
Balance Sheet
|
Ratios
Income Overview
Revenue
$45,250K
Net Income
$44,717K
Net Profit Margin
98.82%
EPS
$1.07
Unit: Thousand (K) dollars
Subscribe for Financial Insights
Page 1
Quarterly
123
Page 1
Income Statement
2025-09-30
2025-06-30
2025-03-31
2024-12-31
Collaboration revenues
45,250
0
3,729
759*
Research and development
197
2,424
9,156
19,724*
General and administrative
1,239
3,354
3,907
5,994*
Total operating expenses
1,436
5,778
13,063
25,717*
Operating loss
43,814
-5,778
-9,334
-24,958*
Gain (loss) on sale of held for sale assets
320
-3,539
-
-
Loss on abandonment of operating lease right-of-use asset
0
927
-
-
Interest income, net
-
-
68
277*
Other income, net
583
470
-
-
Pre-tax income(loss)
44,717
-9,774
-9,266
-
Income tax expense
0
0
-
-
Net income(loss)
44,717
-9,774
-9,266
-24,681
Comprehensive loss
-
-
-
-24,681
Basic EPS
1.07
-0.23
-0.22
-0.595
Diluted EPS
1.07
-0.23
-0.22
-0.595
Basic Average Shares
41,788,096
41,788,096
41,771,213
41,456,210*
Diluted Average Shares
41,940,292
41,788,096
41,771,213
41,456,210*
Page 1
Unit: Thousand (K) dollars (except for numbers of shares and EPS). Numbers labeled with * are estimated quarterly values.
Page 1
Buy us a coffee
Time Plot
Show the time plot by selecting a row from the table.
Income Statement
Collaboration revenues
$45,250K
(1236.78%↑ Y/Y)
Operating loss
$43,814K
(433.34%↑ Y/Y)
Other income, net
$583K
Gain (loss) on sale of
held for sale assets
$320K
Total operating
expenses
$1,436K
(-91.31%↓ Y/Y)
Pre-tax income(loss)
$44,717K
(452.05%↑ Y/Y)
General and
administrative
$1,239K
(-76.19%↓ Y/Y)
Research and development
$197K
(-98.26%↓ Y/Y)
Net income(loss)
$44,717K
(452.05%↑ Y/Y)
Buy us a coffee
Carisma Therapeutics Inc. (CARM)
Carisma Therapeutics Inc. (CARM)